about
Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of VaterSkp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumoursGalectin-1 and its involvement in hepatocellular carcinoma aggressivenessPrognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients.MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosisChromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approach.High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.NK cells and T cells cooperate during the clinical course of colorectal cancer.High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancerPD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patientsAn update on molecular genetics of gastrointestinal stromal tumours.PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer.Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancerA simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.Diffuse minute clear cell proliferation in kidney: case report and review of literature.Patterns of liver infiltration in lymphoproliferative disease.Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosisHLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic markerHuman Papillomavirus (HPV) Detection in Cytologic Specimens: Similarities and Differences of Available Methodology.Coexistence of primary gastric giant cell-rich leiomyosarcoma and gastrointestinal stromal tumor: report of a very rare combination and review of the literature.The RNA-binding protein RBM3 is required for cell proliferation and protects against serum deprivation-induced cell death.Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.Hands-On Experience: Accreditation of Pathology Laboratories according to ISO 15189.Clinicopathological Features and Metastatic Pattern of Hepatocellular Carcinoma: An Autopsy Study of 398 Patients.Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.Prognostic value of apoptotic index in cutaneous basal cell carcinomas of head and neck.KIT, PDGFRalpha and EGFR analysis in nephroblastoma.Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
P50
Q28302252-49056479-81C2-4F23-8E70-4836CD66C25AQ33333993-871972C4-44CA-44B6-BE7A-23FAB7EECDB7Q33692511-1A426E9D-AF24-492E-BABE-465ECF6CA69DQ34059673-1B745121-BDE4-4C5D-A1BF-E257CF0AD2FFQ34120439-EDE814B9-3AA8-43B7-B704-470BBAAF1BA8Q34196069-104ABB16-1B34-4ABE-B964-3BA2FB90AD6FQ34376920-B4ED0C57-F5B7-418B-A0BD-44C0506CCAD7Q34389482-F0D2129E-156E-4209-A2E0-71B775154262Q34743477-407F099B-A943-4CB0-8C8A-6208F1C4014DQ34755696-E591E2EF-ECA0-4D4E-9E7F-C8ED48279983Q34933101-E62BFC5E-2C66-443D-824B-EA8372EF3CA0Q34950886-A235999C-5AC3-4368-8F0C-E5622992AAABQ35677709-2CDA4290-B9B4-4402-A550-01C423B23C56Q35770066-C60D63AF-BA2A-442D-A0EE-8B8DBAA5FA27Q35886689-67E98462-45EF-4F55-B559-6D2B4A4B9820Q36014430-EC654AD2-AED7-4DBE-9A59-00D586F0F24CQ36184983-57683DB4-0CD8-4F23-B127-779ABF3062F7Q36255726-70439603-3459-4180-91AE-787ECA6101FFQ36545813-923183E9-6637-4F51-AAFB-06CAC0652235Q36609946-E48CC68F-6815-4DA3-AC26-28244F8F3394Q36613499-7B4D1F34-E267-47EB-8522-23B47297B441Q37133489-06F0385A-CCB5-464F-A669-725327AB6803Q37186824-314CAF43-348A-4B82-BC02-DE7BBF1E01B8Q37229927-27A4FD10-5A42-4B6F-A411-AC6A3AA163B5Q37302680-A02B15FB-D455-42D4-87E2-A7D4DECEE618Q37584313-4CADBBFF-C6FE-4CD0-8004-573A267842B2Q37713244-29F2A58A-E905-446F-8339-5B95688760ACQ37899659-3464D48D-8F9A-46A2-AD0B-1CBF005382B0Q38350266-A7B831E2-EF59-47E1-A3B1-EC8B5C55EB34Q39009644-30287F8A-3B21-4411-947B-65D8475D2063Q39030791-C7E8A130-DCDD-4AE4-A1CF-CD9096B47DB0Q39672748-EBF86A1D-412F-4C1A-91C9-B61E5EA1966DQ40856391-6D6C67F3-842A-48B8-ACB0-6E583592CFCFQ41143701-83533D3C-AB81-4670-BA90-EE9039244171Q41308137-6D5D2EDD-EA48-41DD-A64A-B4A6D759B544Q42484601-ED5918E0-5A24-4622-879A-F6FDC0CAFAE0Q42655265-D86AF913-4DE9-48C8-98A5-83D0DD9F505AQ42981021-C5B95971-5B57-46C5-BB56-1091D48DD066Q43599702-24C2D489-3D6B-4D17-94FE-665C7A0FA2BBQ43855463-25820C28-6F3D-4CC5-BBB5-2B6CA6669407
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luigi Tornillo
@ast
Luigi Tornillo
@en
Luigi Tornillo
@es
Luigi Tornillo
@nl
Luigi Tornillo
@sl
type
label
Luigi Tornillo
@ast
Luigi Tornillo
@en
Luigi Tornillo
@es
Luigi Tornillo
@nl
Luigi Tornillo
@sl
prefLabel
Luigi Tornillo
@ast
Luigi Tornillo
@en
Luigi Tornillo
@es
Luigi Tornillo
@nl
Luigi Tornillo
@sl
P106
P1153
6603626042
P21
P31
P496
0000-0003-3610-3733